Eisai Co (Eisai Co) Days Inventory

: 374.38 (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

Days Inventory is also known as Days Sales of Inventory (DSI). Eisai Co's Average Total Inventories for the three months ended in Dec. 2023 was $1,108 Mil. Eisai Co's Cost of Goods Sold for the three months ended in Dec. 2023 was $270 Mil. Hence, Eisai Co's Days Inventory for the three months ended in Dec. 2023 was 374.38.

The historical rank and industry rank for Eisai Co's Days Inventory or its related term are showing as below:

ESAIY' s Days Inventory Range Over the Past 10 Years
Min: 138.8 Med: 157.91 Max: 339.78
Current: 339.78

During the past 13 years, Eisai Co's highest Days Inventory was 339.78. The lowest was 138.80. And the median was 157.91.

ESAIY's Days Inventory is ranked worse than
87.38% of 975 companies
in the Drug Manufacturers industry
Industry Median: 157.96 vs ESAIY: 339.78

Eisai Co's Days Inventory increased from Dec. 2022 (223.16) to Dec. 2023 (374.38). It might indicate that Eisai Co's sales slowed down.

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Eisai Co's Inventory Turnover for the three months ended in Dec. 2023 was 0.24.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Eisai Co's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.90.

Eisai Co Days Inventory Historical Data

The historical data trend for Eisai Co's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Inventory

Get a 7-Day Free Trial

151.06

136.60

171.38

200.28

258.63

Eisai Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Inventory	Get a 7-Day Free Trial															223.16	307.79	310.02	396.79	374.38

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eisai Co Days Inventory Distribution

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Days Inventory distribution charts can be found below:

* The bar in red indicates where Eisai Co's Days Inventory falls into.

Eisai Co Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Eisai Co's Days Inventory for the fiscal year that ended in Mar. 2023 is calculated as

	Days Inventory (A: Mar. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Mar. 2022 )	+	Total Inventories (A: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2023 )	*	Days in Period
=	( (834.965	+	1050.52)	/	2 )	/	1330.468	*	365
=	942.7425					/	1330.468	*	365
=	258.63

Eisai Co's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (1082.032	+	1133.798)	/	2 )	/	270.041	*	365 / 4
=	1107.915					/	270.041	*	365 / 4
=	374.38

Eisai Co (OTCPK:ESAIY) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Eisai Co's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	270.041	/	1107.915
	=	0.24

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Eisai Co's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	1107.915	/	1234.207
	=	0.90

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Eisai Co Days Inventory Related Terms

Thank you for viewing the detailed overview of Eisai Co's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Eisai Co (Eisai Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (OTCPK:ESAIY) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

ESALF:USA 4523:Japan EII:Germany

Address

4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088

Website

http://www.eisai.co.jp

Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.